Detalhe da pesquisa
1.
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.
Blood
; 141(12): 1457-1468, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564031
2.
A hemophilia A mouse model for the in vivo assessment of emicizumab function.
Blood
; 136(6): 740-748, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369559
3.
Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A.
Cell Immunol
; 325: 64-68, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29395036
4.
Biochemical characterization and immunogenicity of Neureight, a recombinant full-length factor VIII produced by fed-batch process in disposable bioreactors.
Cell Immunol
; 331: 22-29, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29751951
5.
Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
Haematologica
; 103(1): 172-178, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29025906
6.
Complement C3 is a novel modulator of the anti-factor VIII immune response.
Haematologica
; 103(2): 351-360, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146705
7.
Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.
Haematologica
; 103(6): 1083-1092, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567779
8.
Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.
J Immunol
; 196(10): 4075-81, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27067006
9.
The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.
Haematologica
; 102(2): 271-281, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27758819
10.
The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope.
Haematologica
; 102(11): 1833-1841, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751567
11.
Hunting down factor VIII in the immunopeptidome.
Cell Immunol
; 301: 59-64, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26610639
12.
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient.
Haematologica
; 106(8): 2287-2290, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011136
13.
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.
Haematologica
; 98(10): 1650-5, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716558
14.
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
J Thromb Haemost
; 21(10): 2776-2783, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473843
15.
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy.
J Thromb Haemost
; 21(9): 2405-2417, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271431
16.
Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein S.
J Thromb Haemost
; 20(7): 1653-1664, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445541
17.
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization.
Res Pract Thromb Haemost
; 6(4): e12737, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734101
18.
Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance.
Front Immunol
; 11: 810, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477339
19.
Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications.
Res Pract Thromb Haemost
; 4(7): 1087-1110, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33134775
20.
Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.
Front Immunol
; 9: 1251, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29951051